Medical Xpress January 2, 2025
Jennifer James, University of Liverpool

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent pharmaceutical advances have led to the development of weight loss drugs. These are based on natural hormones from the intestine that help control food intake, such as GLP and GIP.

GLP-1-based drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro) work by helping people to feel less hungry. This results in them eating less—leading to weight loss.

Studies show that these drugs are very effective in helping people lose weight. In clinical trials of people with obesity, these drugs lead to a weight loss of up to 20% body weight in some instances.

But it’s important to note that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Lotte Bjerre Knudsen: The Scientist Who Drove GLP-1 Drugs For Obesity and Alzheimer's
Most influential drug approvals of 2024: GoodRx
Trump May Revisit Most Favored Nation Model for Prescription Drug Prices
AI’s moment in preclinical drug development arrives: Why formulation tech is the next frontier
Use of diabetes and anti-obesity drugs surges nationwide

Share This Article